Our debt and equity research products
We embrace a simple research philosophy: provide fundamental, independent ideas that add value for our clients. We only make money through the value of our analysis.
Our Telecoms team provides research coverage of 78 European and Emerging Market Telecom Services, Cable and Tower operators, whilst our Healthcare group has 14 European Healthcare companies and 4 Japanese Pharmaceutical companies under coverage. We constantly review our stock universe to identify further opportunities for our investor clients.
Our research products include:
- Idea-driven company research notes, recommendations and target prices, together with full interactive financial models, forecasts and comparables. We analyse the entire capital structure of the companies we cover and, where appropriate, we integrate high-yield research into our product;
- Thematic research, linked to clear stock recommendations, providing our clients a homogenous view of the relevant sector, embracing regulatory, competitive and technology issues;
- Company meeting notes;
- Comprehensive sector valuation, multiples and operating data, updated weekly.
We can tailor delivery of our research to specific investor requirements. We offer one-on-one meetings with investors; we can provide regular telephone, conference call, email and Bloomberg interaction with portfolio managers and buy-side analysts, as requested; and assist investors in company meetings.